Jason A. Roberts

52.2k total citations · 6 hit papers
693 papers, 28.0k citations indexed

About

Jason A. Roberts is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Jason A. Roberts has authored 693 papers receiving a total of 28.0k indexed citations (citations by other indexed papers that have themselves been cited), including 474 papers in Pharmacology, 243 papers in Epidemiology and 178 papers in Molecular Medicine. Recurrent topics in Jason A. Roberts's work include Antibiotics Pharmacokinetics and Efficacy (470 papers), Antibiotic Resistance in Bacteria (178 papers) and Pneumonia and Respiratory Infections (143 papers). Jason A. Roberts is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (470 papers), Antibiotic Resistance in Bacteria (178 papers) and Pneumonia and Respiratory Infections (143 papers). Jason A. Roberts collaborates with scholars based in Australia, France and United States. Jason A. Roberts's co-authors include Jeffrey Lipman, Andrew Udy, David L. Paterson, Steven C. Wallis, Michael S. Roberts, Mohd H. Abdul‐Aziz, Fekade B. Sime, Brett McWhinney, Jacobus Ungerer and Jordi Rello and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Physical Review Letters.

In The Last Decade

Jason A. Roberts

664 papers receiving 27.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

2016 2.3k citations André C. Kalil, Mark L. Metersky et al. Clinical Infectious Diseases profile →
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

2014 703 citations Jason A. Roberts, Mohd H. Abdul‐Aziz et al. profile →
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

2020 640 citations Mohd H. Abdul‐Aziz, Matteo Bassetti et al. Intensive Care Medicine profile →
Pharmacokinetic issues for antibiotics in the critically ill patient

2009 627 citations Jason A. Roberts, Jeffrey Lipman profile →
Obesity in the critically ill: a narrative review

2019 324 citations Jason A. Roberts et al. Intensive Care Medicine profile →
Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

2016 289 citations André C. Kalil, Mark L. Metersky et al. Clinical Infectious Diseases profile →

Peers

Countries citing papers authored by Jason A. Roberts

Since Specialization

Citations

This map shows the geographic impact of Jason A. Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason A. Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason A. Roberts more than expected).

Fields of papers citing papers by Jason A. Roberts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason A. Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason A. Roberts. The network helps show where Jason A. Roberts may publish in the future.

Co-authorship network of co-authors of Jason A. Roberts

This figure shows the co-authorship network connecting the top 25 collaborators of Jason A. Roberts. A scholar is included among the top collaborators of Jason A. Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason A. Roberts. Jason A. Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ceftriaxone population pharmacokinetics in plasma and cerebrospinal fluid of neurocritical care patients 2025 ·International Journal of Antimicrobial Agents ·(unknown), Aaron J. Heffernan, Xin Liu, Suzanne L. Parker, Menino Osbert Cotta, Steven C. Wallis, (unknown), Therese Starr, (unknown), Gavin M. Joynt, Jeffrey Lipman, Jason A. Roberts	0
2	Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey 2025 ·JAC-Antimicrobial Resistance ·(unknown), Jason A. Roberts, Luis Eduardo López-Cortés, (unknown), James Pollard, (unknown), Mohd H. Abdul‐Aziz, C Jamieson, R.A. Seaton, Mary J.R. Gilchrist, Fekade B. Sime	2
3	Outpatient parenteral antimicrobial therapy with carbapenems: A systematic review 2024 ·Journal of Infection ·(unknown), Jason A. Roberts, (unknown), Steve Unwin, Kate McCarthy, Fekade B. Sime	3
4	Renal function and its impact on the concentration of ceftazidime-avibactam: A cross-sectional study 2024 ·International Journal of Antimicrobial Agents ·(unknown), Simone Giuliano, Jacopo Angelini, (unknown), (unknown), Massimo Baraldo, (unknown), Jason A. Roberts, Carlo Tascini	3
5	Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis 2023 ·Critical Care ·Emmanuel Novy, Claire Roger, Jason A. Roberts, Menino Osbert Cotta	5
6	Beta-Lactam Dose Optimisation in the Intensive Care Unit: Targets, Therapeutic Drug Monitoring and Toxicity 2023 ·Antibiotics ·(unknown), (unknown), Ming G. Chai, Jason A. Roberts, Menino Osbert Cotta	18
7	Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review 2022 ·Clinical Pharmacokinetics ·(unknown), Steven Y. C. Tong, Justin T. Denholm, Gregory J. Dore, Asha C Bowen, Sharon R. Lewin, Balasubramanian Venkatesh, Thomas Hills, Zoe McQuilten, David L. Paterson, Susan C. Morpeth, Jason A. Roberts	17
8	Physician drug prescribing preferences and availability for ventilation of patients with COVID-19 2020 ·Critical Care and Resuscitation ·Ian Coombes, Michael Dooley, (unknown), (unknown), Susan Poole, (unknown), Brent Richards, Marc Ziegenfuss, (unknown), (unknown), Jason A. Roberts, Anthony Holley	1
9	Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic In Vitro Hollow-Fiber Infection Model 2020 ·Antimicrobial Agents and Chemotherapy ·Aaron J. Heffernan, Fekade B. Sime, Derek S. Sarovich, Michael Neely, Yarmarly C. Guerra Valero, (unknown), Kyra Cottrell, Patrick N. A. Harris, Katherine T. Andrews, David Ellwood, Steven C. Wallis, Jeffrey Lipman, Keith Grimwood, Jason A. Roberts	8
10	A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III 2019 ·Critical Care and Resuscitation ·Jeffrey Lipman, Stephen J. Brett, Jan J. De Waele, Menino Osbert Cotta, Joshua S. Davis, Simon Finfer, Parisa Glass, Serena Knowles, Shay McGuinness, John Myburgh, David L. Paterson, Sandra Peake, Dorrilyn Rajbhandari, Andrew Rhodes, Jason A. Roberts, Charudatt Shirwadkar, Therese Starr, Colman Taylor, Laurent Billot, Joel M. Dulhunty	35
11	Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP) 2019 ·Intensive Care Medicine ·Alexis Tabah, Matteo Bassetti, (unknown), J.-R. Zahar, José Artur Paiva, Jean‐François Timsit, Jason A. Roberts, Jeroen Schouten, Helen Giamarellou, Jordi Rello, Jan J. De Waele, Andrew F. Shorr, Marc Léone, Garyphallia Poulakou, Pieter Depuydt, José Garnacho‐Montero	102
12	Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models 2018 ·Journal of Antimicrobial Chemotherapy ·Sofie Dhaese, (unknown), Pieter Colin, Jeffrey Lipman, Veronique Stove, Alain Verstraete, Jason A. Roberts, Jan J. De Waele	48
13	Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy 2018 ·International Journal of Antimicrobial Agents ·(unknown), Jan T. Kielstein, David Czock, Jiao Xie, Jonathan Field, Brent Richards, Mandy Tallott, (unknown), (unknown), Carsten Hafer, Julius J. Schmidt, Jeffrey Lipman, Jason A. Roberts	24
14	The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections 2017 ·Intensive Care Medicine ·Thomas Tängdén, Véronique Martin, Tim Felton, Elisabet I. Nielsen, Sandrine Marchand, Roger J. M. Brüggemann, Jürgen B. Bulitta, Matteo Bassetti, Ursula Theuretzbacher, Brian T. Tsuji, David W. Wareham, Lena E. Friberg, Jan J. De Waele, Vincent H. Tam, Jason A. Roberts	89
15	Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society breakdown → 2016 ·Clinical Infectious Diseases ·André C. Kalil, Mark L. Metersky, Michael Klompas, John Muscedere, Daniel A. Sweeney, Lucy B. Palmer, Lena M. Napolitano, Naomi P. O’Grady, John G. Bartlett, Jordi Carratalà, Ali A. El Solh, Santiago Ewig, Paul D. Fey, Thomas M. File, Marcos I. Restrepo, Jason A. Roberts, Grant Waterer, Peggy Cruse, Shandra L. Knight, Jan Brożek	2347
16	How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy? 2015 ·Diagnostic Microbiology and Infectious Disease ·Janattul‐Ain Jamal, Bruce A. Mueller, Gordon Choi, Jeffrey Lipman, Jason A. Roberts	57
17	A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study 2013 ·Critical Care and Resuscitation ·Joel M. Dulhunty, Jason A. Roberts, Joshua S. Davis, S. A. R. Webb, Rinaldo Bellomo, Charles D. Gomersall, Charudatt Shirwadkar, Glenn M. Eastwood, John Myburgh, David L. Paterson, Therese Starr, Andrew Udy, Sanjoy K. Paul, Jeffrey Lipman	15
18	The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration 2013 ·Critical Care and Resuscitation ·(unknown), (unknown), Brett McWhinney, Carel Pretorius, Jason A. Roberts, Jeremy Cohen, Balasubramanian Venkatesh	1
19	Therapeutic drug monitoring when using cefepime in continuous renal replacement therapy: seizures associated with cefepime 2012 ·Critical Care and Resuscitation ·Nicholas Smith, Ross Freebairn, (unknown), Steven C. Wallis, Jason A. Roberts, Jeffrey Lipman	36
20	A survey of antibiotic prescribing practices in Australian and New Zealand intensive care units 2010 ·Critical Care and Resuscitation ·Joel M. Dulhunty, S. A. R. Webb, David L. Paterson, Rinaldo Bellomo, John Myburgh, Jason A. Roberts, Jeffrey Lipman	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact